Limitless Pharma
ActiveSummary
The computed 12-month bankruptcy probability of Limitless Pharma is 4.1% (elevated). The 2025 annual accounts show negative equity (-€22,918) and a net result of -€18,605. Its solvency ranks better than 9% of 22,153 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
no sitting director read yet, last change in 2025
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Mandate history
1 person since 2025, 0 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Libert Philip |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.